Showing results (71-80 of 117) with videos related to
Sort By:
Pageof 12
Journal of the European Academy of Dermatology and Venereology : JEADV|October 29, 2011
Cost-effectiveness evaluation of clobetasol propionate shampoo (CPS) maintenance in patients with moderate scalp psoriasis: a Pan-European analysisK Papp, Y Poulin, K Barber, et al.Nature Communications|November 4, 2018
Alleviating oxygen evolution from Li-excess oxide materials through theory-guided surface protectionYongwoo Shin, Wang Hay Kan, Muratahan Aykol, et al.Teaching and Learning in Medicine|January 22, 2013
The required written history and physical is alive, but not entirely well, in internal medicine clerkshipsTemple A Ratcliffe, Janice L Hanson, Paul A Hemmer, et al.Academic Medicine : Journal of the Association of American Medical Colleges|October 22, 2015
Educating for the 21st-Century Health Care System: An Interdependent Framework of Basic, Clinical, and Systems SciencesJed D Gonzalo, Paul Haidet, Klara K Papp, et al.The British Journal of Dermatology|February 7, 2018
Efficacy and safety of continuous every-2-week dosing of ixekizumab over 52 weeks in patients with moderate-to-severe plaque psoriasis in a randomized phase III trial (IXORA-P)R G Langley, K Papp, M Gooderham, et al.Medical Teacher|October 9, 2009
Medical informatics in the internal medicine clerkship: Results of a national surveyMeenakshy K Aiyer, Josephine L Dorsch, Matthew Mintz, et al.Academic Medicine : Journal of the Association of American Medical Colleges|February 6, 1999
Performance of third-year primary-care-track students in an integrated curriculum at Case Western Reserve UniversityL O Lewin, K K Papp, S L Hodder, et al.The British Journal of Dermatology|November 19, 2010
Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapyK Papp, J Crowley, J-P Ortonne, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 11, 2021
Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis: phase 3 open-label studyM G Lebwohl, L Stein Gold, K Papp, et al.Sleep|May 17, 2003
Competency-based goals for sleep and chronobiology in undergraduate medical educationKingman P Strohl, Sigrid Veasey, Susan Harding, et al.Pageof 12